Brief: Todos Medical Announces US FDA Emergency Use Authorization Allowed for Gnomegen COVID-19 PCR Test Kits
21/04/2020 23:15
April 21 (Reuters) - Todos Medical Ltd TOMDF.PK :
* TODOS MEDICAL - RECEIVED EMERGENCY USE AUTHORIZATION FROM
THE
FDA FOR ITS REAL-TIME DIGITAL POLYMERASE CHAIN REACTION
DIAGNOSTIC TEST FOR COVID-19
Source text: (http://www.sec.gov/archives/edgar/data/1645260/000149315220006837/0001493152-20-006837-index.htm
)
Further company coverage: TOMDF.PK
((Reuters.briefs@thomsonreuters.com;))
Recent news on Todos Medical
See all newsBrief: Todos Medical Enters Into Exclusive Worldwide Automated Retail Supply Agreement With Smart Automated Retail Network
Brief: Todos Medical Clia/Cap Lab Provista Submits Emergency Use Authorization Application For Monkeypox Pcr Test To Us FDA
Brief: Todos Medical Provides Corporate Update
Brief: Todos Medical Enters Into $50 Mln Contract To Supply Tollovid, CBD Products To Retail Distributor Company Nerd Hemp
Brief: Todos Medical Establishes Botanical Supplement Manufacturing Capabilities